Market Overview:
Defibrillators are medical devices used to deliver therapeutic shock to patients in sudden cardiac arrest. They help restore normal heart rhythm. There are various types of defibrillators including implantable cardioverter defibrillators, external defibrillators and automated external defibrillators. With rising incidence of cardiac diseases, the need for defibrillators is increasing globally.

Market key trends:
One of the key trends in the defibrillators market is increasing demand for automated external defibrillators. Automated external defibrillators (AEDs) are portable defibrillators used by lay persons to provide life-saving defibrillation on victims of sudden cardiac arrest. With rising awareness about importance of early defibrillation, there is growing adoption of AEDs in public places like airports, schools, shopping malls etc. According to the American Heart Association, early defibrillation (within 3 to 5 minutes of collapse) can increase survival rates as high as 50% to 70% from sudden cardiac arrest. This is a major factor fueling growth of the AEDs segment in the defibrillators market.
Segment Analysis
The Global Defibrillators Market Share is segmented into external defibrillators and implanted cardioverter defibrillators (ICDs). The external defibrillators segment dominated the market in 2023 and is expected to continue its dominance over the forecast period due to rising incidence of sudden cardiac arrest (SCA) and increasing demand for public-access defibrillators. Automated external defibrillators (AEDs) form a major sub-segment within external defibrillators due to their user-friendly operation and ability to effectively treat SCA when used by bystanders or first responders.

Key Takeaways
The global defibrillators market is expected to witness high growth, exhibiting a CAGR of 5.7% over the forecast period, due to increasing incidence of cardiac diseases and growing focus on providing public access to defibrillators.

The North America region dominated the global market in 2023 with a share of over 35%, owing to rising prevalence of cardiovascular diseases, ongoing technological advancements, and growing need for public-access defibrillators in the region. The Asia Pacific region is expected to exhibit the highest CAGR during the forecast period owing to rapidly aging population, economic growth, and improving healthcare infrastructure in emerging countries.

Key players operating in the defibrillators market include Koninklijke Philips N.V., Medtronic, Boston Scientific Corporation, Abbott, BIOTRONIK, and LivaNova PLC. These players focus on new product launches, approvals, and expanding their global presence through collaborations and partnerships to strengthen their market position. For instance, in 2022, Philips received approval from the US FDA for its HeartStart FR3 and HeartStart FRx defibrillators designed to be easy and intuitive to use for public access.

Read More:

https://perfectinsights.blogspot.com/2023/11/the-defibrillators-market-is-estimated.html